Putaminal dopamine modulates movement motivation in Parkinson's disease

被引:1
|
作者
Banwinkler, Magdalena [1 ,2 ]
Dzialas, Verena [1 ,2 ,3 ]
Rigoux, Lionel [4 ]
Asendorf, Adrian L. [1 ,2 ]
Theis, Hendrik [1 ,2 ,5 ]
Giehl, Kathrin [1 ,2 ,6 ]
Tittgemeyer, Marc [4 ,7 ]
Hoenig, Merle C. [1 ,2 ,6 ]
van Eimeren, Thilo [1 ,2 ,5 ]
机构
[1] Univ Cologne, Fac Med, D-50937 Cologne, Germany
[2] Univ Hosp Cologne, Dept Nucl Med, Kerpener Str 62, D-50937 Cologne, NRW, Germany
[3] Univ Cologne, Fac Math & Nat Sci, D-50939 Cologne, Germany
[4] Max Planck Inst Metab Res, D-50931 Cologne, Germany
[5] Univ Hosp Cologne, Dept Neurol, D-50937 Cologne, Germany
[6] Res Ctr Juelich, Mol Org Brain, Inst Neurosci & Med 2, D-52425 Julich, Germany
[7] Univ Cologne, Fac Med, Cologne Excellence Cluster Cellular Stress Respons, D-50931 Cologne, Germany
关键词
incentive salience; fatigue; SPECT; imaging; basal ganglia; performance; REWARD; FORCE; MOTOR; MONEY;
D O I
10.1093/brain/awae214
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The relative inability to produce effortful movements is the most specific motor sign of Parkinson's disease, which is primarily characterized by loss of dopaminergic terminals in the putamen. The motor motivation hypothesis suggests that this motor deficit may not reflect a deficiency in motor control per se, but a deficiency in cost-benefit considerations for motor effort. For the first time, we investigated the quantitative effect of dopamine depletion on the motivation of motor effort in Parkinson's disease.A total of 21 early-stage, unmedicated patients with Parkinson's disease and 26 healthy controls were included. An incentivized force task was used to capture the amount of effort participants were willing to invest for different monetary incentive levels and dopamine transporter depletion in the bilateral putamen was assessed.Our results demonstrate that patients with Parkinson's disease applied significantly less grip force than healthy controls, especially for low incentive levels. Congruously, decrease of motor effort with greater loss of putaminal dopaminergic terminals was most pronounced for low incentive levels. This signifies that putaminal dopamine is most critical to motor effort when the trade-off with the benefit is poor.Taken together, we provide direct evidence that the reduction of effortful movements in Parkinson's disease depends on motivation and that this effect is associated with putaminal dopaminergic degeneration. Using an incentivized grip force task, Banwinkler et al. show that the reduction of effortful movements in Parkinson's disease is associated with putaminal dopaminergic degeneration. Dopamine depletion results in reduced motivation for motor effort, particularly in low reward conditions.
引用
收藏
页码:3352 / 3357
页数:6
相关论文
共 50 条
  • [31] Dopamine and eye movement control in Parkinson's disease: deficits in corollary discharge signals?
    Railo, Henry
    Olkoniemi, Henri
    Eeronheimo, Enni
    Paakkonen, Oona
    Joutsa, Juho
    Kaasinen, D. Valtteri
    PEERJ, 2018, 6
  • [32] Dopamine transporter and Parkinson's disease
    Nakamura, S
    Kawakami, H
    Morino, H
    Kawarai, T
    Yamashita, H
    Takahashi, T
    Mitsuoka, T
    Kaseda, Y
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 467 - 470
  • [33] Dopamine agonists for Parkinson's disease
    Sharma, J
    MacMahon, D
    Stewart, D
    LANCET, 2003, 361 (9351): : 84 - 84
  • [34] Dopamine, Parkinson's disease, and volition
    Horvitz, JC
    BEHAVIORAL AND BRAIN SCIENCES, 2002, 25 (05) : 586 - +
  • [35] Dopamine Receptors and Parkinson's Disease
    Hisahara, Shin
    Shimohama, Shun
    INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2011, 2011
  • [36] Dopamine agonists in Parkinson's disease
    Tintner, R
    Jankovic, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1803 - 1820
  • [37] Intracerebroventricular dopamine for Parkinson's disease
    Devos, David
    Devedjian, Jean-Christophe
    Moreau, Caroline
    ONCOTARGET, 2017, 8 (28) : 45034 - 45035
  • [38] Extrastriatal dopamine and Parkinson's disease
    Parent, A
    Cossette, M
    PARKINSON'S DISEASE, 2001, 86 : 45 - 54
  • [39] Dopamine and Parkinson's disease - Introduction
    Triarhou, LC
    DOPAMINERGIC NEURON TRANSPLANTATION IN THE WEAVER MOUSE MODEL OF PARKINSON'S DISEASE, 2002, 517 : 1 - 14
  • [40] Evaluation of the motivation of family doctors in providing care to patients with Parkinson's disease and movement disorders
    Korzh, O. M.
    Krasnokutskiy, S. V.
    Lavrova, E. V.
    MOVEMENT DISORDERS, 2013, 28 : S425 - S426